Abstract:Purpose: Artificial intelligence-based tools can be leveraged to improve detection and segmentation of brain metastases for stereotactic radiosurgery (SRS). VBrain by Vysioneer Inc. is a deep learning algorithm with recent FDA clearance to assist in brain tumor contouring. We aimed to assess the performance of this tool by various demographic and clinical characteristics among patients with brain metastases treated with SRS. Materials and methods: We randomly selected 100 patients with brain metastases who underwent initial SRS on the CyberKnife from 2017 to 2020 at a single institution. Cases with resection cavities were excluded from the analysis. Computed tomography (CT) and axial T1-weighted post-contrast magnetic resonance (MR) image data were extracted for each patient and uploaded to VBrain. A brain metastasis was considered "detected" when the VBrain- "predicted" contours overlapped with the corresponding physician contours ("ground-truth" contours). We evaluated performance of VBrain against ground-truth contours using the following metrics: lesion-wise Dice similarity coefficient (DSC), lesion-wise average Hausdorff distance (AVD), false positive count (FP), and lesion-wise sensitivity (%). Kruskal-Wallis tests were performed to assess the relationships between patient characteristics including sex, race, primary histology, age, and size and number of brain metastases, and performance metrics such as DSC, AVD, FP, and sensitivity. Results: We analyzed 100 patients with 435 intact brain metastases treated with SRS. Our cohort consisted of patients with a median number of 2 brain metastases (range: 1 to 52), median age of 69 (range: 19 to 91), and 50% male and 50% female patients. The primary site breakdown was 56% lung, 10% melanoma, 9% breast, 8% gynecological, 5% renal, 4% gastrointestinal, 2% sarcoma, and 6% other, while the race breakdown was 60% White, 18% Asian, 3% Black/African American, 2% Native Hawaiian or other Pacific Islander, and 17% other/unknown/not reported. The median tumor size was 0.112 c.c. (range: 0.010-26.475 c.c.). We found mean lesion-wise DSC to be 0.723, mean lesion-wise AVD to be 7.34% of lesion size (0.704 mm), mean FP count to be 0.72 tumors per case, and lesion-wise sensitivity to be 89.30% for all lesions. Moreover, mean sensitivity was found to be 99.07%, 97.59%, and 96.23% for lesions with diameter equal to and greater than 10 mm, 7.5 mm, and 5 mm, respectively. No other significant differences in performance metrics were observed across demographic or clinical characteristic groups. Conclusion: In this study, a commercial deep learning algorithm showed promising results in segmenting brain metastases, with 96.23% sensitivity for metastases with diameters of 5 mm or higher. As the software is an assistive AI, future work of VBrain integration into the clinical workflow can provide further clinical and research insights.

Automatic Detection of Brain Metastases Using 3D Mask R-CNN for Stereotactic Radiosurgery

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Deep Learning-Based Automatic Segmentation for Size and Volumetric Measurement of Breast Cancer on Magnetic Resonance Imaging.

Post-Op Brain Tumor Bed Detection and Segmentation Using 3D Mask R-CNN for Dynamic Magnetic Resonance Perfusion Imaging

Deep Learning-Based Detection and Segmentation-Assisted Management of Brain Metastases

Brain Tumor Segmentation Using 3D Mask R-CNN for Dynamic Susceptibility Contrast Enhanced Perfusion Imaging.

Deep Learning-Based Brain Tumor Bed Segmentation for Dynamic Magnetic Resonance Perfusion Imaging

A web-based brain metastases segmentation and labeling platform for stereotactic radiosurgery

MRI-based two-stage deep learning model for automatic detection and segmentation of brain metastases

Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery

Prostate cancer of magnetic resonance imaging automatic segmentation and detection of based on 3D-Mask RCNN

Deep-learning and radiomics ensemble classifier for false positive reduction in brain metastases segmentation

SRTRP-Net: A multi-task learning network for segmentation and prediction of stereotactic radiosurgery treatment response in brain metastases

Brain metastases detection on MR by means of three-dimensional tumor-appearance template matching

Multi-organ auto-delineation in head-and-neck MRI for radiation therapy using regional convolutional neural network

Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: A machine learning model

Learning-Based Automatic Segmentation of Arteriovenous Malformations on Contrast CT Images in Brain Stereotactic Radiosurgery

Innv-02. Brainmets: A Clinician-Friendly Software To Manually Segment Brain Metastases And Detect Primary Tumor Origin Using Deep Learning

Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases

Construction and evaluation of a gated high-resolution neural network for automatic brain metastasis detection and segmentation

Automated Lung Tumor Delineation on Positron Emission Tomography/computed Tomography Via a Hybrid Regional Network